Semler Scientific, Inc., a medical technology firm that adopted Bitcoin as its primary treasury asset in 2024, has appointed Joe Burnett as its director of Bitcoin strategy. The move comes as the company intensifies plans to increase its Bitcoin holdings significantly over the next three years.
The company disclosed plans to hold 10,000 Bitcoins by the end of 2025, 42,000 by the end of 2026, and 105,000 by 2027. These purchases will be financed through a combination of equity and debt issuances, as well as operational cash flow.
Three-Year Accumulation Plan
The announcement underscores Semler’s growing focus on Bitcoin as a strategic treasury reserve. Chairman Eric Semler stated that the company is moving forward with a structured multi-year acquisition plan. Semler Scientific became the second publicly listed U.S. firm to adopt a Bitcoin Standard in May 2024.
Since initiating the strategy, the company reported a 287% yield on its Bitcoin holdings and a $177 million unrealized gain as of June 3, 2025. The financial results were not independently verified as part of the announcement.
“We continue to build our holdings based on a conviction that Bitcoin offers long-term financial utility,” Eric Semler said.
New Leadership Role Aims to Strengthen Strategy
Joe Burnett, formerly known for his analysis of Bitcoin and corporate treasury trends, will now oversee the execution of Semler’s crypto-asset strategy. In his new role, Burnett is expected to help guide the company’s acquisition schedule and evaluate evolving market conditions.
In a statement, Burnett said the rise in corporate adoption of Bitcoin signals a broader shift in global monetary systems. “Semler Scientific is positioning itself to expand its Bitcoin treasury in a manner that aligns with shareholder value and long-term asset allocation,” he said.
Bitcoin Holdings as Treasury Asset
Semler’s Bitcoin strategy diverges from traditional corporate treasury practices. Instead of prioritizing fiat or fixed-income assets, the company has placed digital currency at the centre of its financial planning.
As regulatory clarity on digital assets continues to evolve, Semler joins a small but growing list of U.S. firms turning to Bitcoin amid inflationary pressures and market volatility. The company did not provide updates on its core medical technology operations in the announcement.
